Émilie Ducourau
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Spondyloarthritis Studies and Treatments, Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases(2011)158 cited
- → Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis(2014)92 cited
- → Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis(2013)81 cited
- → Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis(2009)66 cited
- → Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis(2010)66 cited
- → Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial(2020)57 cited
- → Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis(2011)53 cited
- → Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study(2011)41 cited
- → Towards an individualised target concentration of adalimumab in rheumatoid arthritis(2014)28 cited
- → Should anti-TNF-α drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?(2012)27 cited